𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Fabrication, implantation, elution, and retrieval of a steroid-loaded polycaprolactone subretinal implant

✍ Scribed by Nathan R. F. Beeley; Juliana V. Rossi; Paulo A. A. Mello-Filho; Mahmoud I. Mahmoud; Gildo Y. Fujii; Eugene de Juan Jr.; Signe E. Varner


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
415 KB
Volume
73A
Category
Article
ISSN
1549-3296

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

A subretinal drug delivery system was developed to overcome the limitations of current treatments for retinal disease. A rod‐shaped implant was made by embedding the corticosteroid triamcinolone acetonide within a biodegradable polycaprolactone polymer matrix. The implant was fabricated by homogenously mixing the polymer and drug in solvent. The mixture was then dried, melted, and extruded, and the prepared solid form was drawn into a filament. The rods were mechanically sectioned to a length of 2 mm with a diameter of up to 320 μm. The rods were successfully implanted into the subretinal space of six rabbits. No complications were observed during the 4‐week follow‐up period. Initial observations of the implantation and elution characteristics revealed that polycaprolactone is well tolerated by the retinal tissue and that the implant can elute steroid for a period of at least 4 weeks without eliciting inflammatory response or complications. In vitro drug elution rates of different polymer to drug ratios and geometries into a balanced salt solution/bovine serum albumin (1%) solution showed an early rapid‐release phase and late first‐order phase. Histology and device retrieval after implantation revealed minimal encapsulation and good preservation of cellular morphology during the follow‐up period and a more fibrous polymer microstructure of the implant. © 2005 Wiley Periodicals, Inc. J Biomed Mater Res, 2005


📜 SIMILAR VOLUMES


Development, implantation, in vivo eluti
✍ Nathan R.F. Beeley; Jay M. Stewart; Ryotaro Tano; Laurie R. Lawin; Ralph A. Chap 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 381 KB 👁 2 views

## Abstract A biocompatible, sustained‐release subretinal drug‐delivery platform was developed to overcome the therapeutic accessibility limitations of current retinal disease treatments. The prototype implants were fabricated by coating nitinol, poly(methyl methacrylate) or chromic gut core filame